STAT+: A breakthrough in pancreatic cancer has experts excited — and braced for what’s to come
Pancreatic cancer specialists are excited about the biggest breakthrough in the field in decades. They are also looking around the corner to what comes next.
Read the full articleYou might also wanna read
STAT+: Eli Lilly to acquire psychedelics-focused biotech AtaiBeckley
STAT·18h ago
STAT+: Amylyx nears pivotal endocrine drug study readout
STAT·19h ago
STAT+: A new biotech startup tries to tackle obesity, but not in the way you might expect
STAT·1d ago
STAT+: Akero team, backed by Fairmount, launches new immunology company
STAT·2d ago
STAT+: Biogen Alzheimer’s drug slowed decline at rates on par with approved therapies, study shows
STAT·2d ago
STAT+: ARPA-H launches $160 million effort to develop custom gene editing drugs
STAT·7d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.